Subscribe To Our Free Newsletter |
Granules India gets USFDA nod for antidepressant tablets
Granules Pharmaceuticals, Inc., a 100% foreign subsidiary of Granules India received the U.S. Food & Drug Administration (USFDA) approval for abbreviated new drug application (ANDA) of Bupropion hydrochloride extended-release tablets USP (SR).